Dr John Buscombe
British Nuclear Medicine Society
Dr John Buscombe is the President of the British Nuclear Medicine Society and works as a Consultant Physician in Nuclear Medicine in Cambridge.
Theranostics in prostate cancer new or false dawn
Over the past 2 years new imaging and therapeutic options using radiolabelled prostate specific membrane antigen have been developed which enable us to see disease which cannot be found by other methods with gallium-68 PSMA PET-CT. Newer work has linked this to targeted radionuclide therapy using beta and alpha emitter labelled PSMA is previously untreatable metastatic prostate cancer which is being actively developed.
EVEN MORE SEMINARS
Dr Jagrit Shah Vice President of the British Society of Head & Neck Imaging
Chairing Session 3. Upper Aerodigestive Tract
Dr Sam Hare Royal Free London NHS Foundation Trust
How I evaluate lung lesions for CT-guided biopsy?
Dr Youssef Mentias CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST
Ultrasound Thyroid Nodule Evaluation
Prof. Iris Grunwald Anglia Ruskin University, School of Medicine; Southend University Hospital
Pioneering treatment mechanical thrombectomy
Estevao Mauricio Bagi Royal Brompton & Harefield Hospitals Specialist Care
Cardiac PET-CT : Rubidium-82 Myocardium Perfusion & 18F-FDG Cardiac Sarcoidosis